Literature DB >> 24799598

A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development.

Martina Sanderson-Smith1, David M P De Oliveira1, Julien Guglielmini2, David J McMillan3, Therese Vu4, Jessica K Holien5, Anna Henningham6, Andrew C Steer7, Debra E Bessen8, James B Dale9, Nigel Curtis10, Bernard W Beall11, Mark J Walker6, Michael W Parker12, Jonathan R Carapetis13, Laurence Van Melderen14, Kadaba S Sriprakash15, Pierre R Smeesters16.   

Abstract

Streptococcus pyogenes ranks among the main causes of mortality from bacterial infections worldwide. Currently there is no vaccine to prevent diseases such as rheumatic heart disease and invasive streptococcal infection. The streptococcal M protein that is used as the substrate for epidemiological typing is both a virulence factor and a vaccine antigen. Over 220 variants of this protein have been described, making comparisons between proteins difficult, and hindering M protein-based vaccine development. A functional classification based on 48 emm-clusters containing closely related M proteins that share binding and structural properties is proposed. The need for a paradigm shift from type-specific immunity against S. pyogenes to emm-cluster based immunity for this bacterium should be further investigated. Implementation of this emm-cluster-based system as a standard typing scheme for S. pyogenes will facilitate the design of future studies of M protein function, streptococcal virulence, epidemiological surveillance, and vaccine development.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  IgA; IgG; M protein; Streptococcus pyogenes; epidemiology; fibrinogen; molecular typing; plasminogen; vaccine

Mesh:

Substances:

Year:  2014        PMID: 24799598      PMCID: PMC6083926          DOI: 10.1093/infdis/jiu260

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  49 in total

1.  Type-specific streptococcal antibody.

Authors:  F W DENNY; W D PERRY; L W WANNAMAKER
Journal:  J Clin Invest       Date:  1957-07       Impact factor: 14.808

2.  Studies on immunity to streptococcal infections in man.

Authors:  L W WANNAMAKER; F W DENNY; W D PERRY; A C SIEGEL; C H RAMMELKAMP
Journal:  AMA Am J Dis Child       Date:  1953-09

3.  Binding of human plasma proteins to Streptococcus pyogenes M protein determines the location of opsonic and non-opsonic epitopes.

Authors:  Charlotta Sandin; Fredric Carlsson; Gunnar Lindahl
Journal:  Mol Microbiol       Date:  2006-01       Impact factor: 3.501

Review 4.  Tissue tropisms in group A streptococcal infections.

Authors:  Debra E Bessen; Sergio Lizano
Journal:  Future Microbiol       Date:  2010-04       Impact factor: 3.165

5.  Identification of a plasminogen-binding motif in PAM, a bacterial surface protein.

Authors:  A C Wistedt; U Ringdahl; W Müller-Esterl; U Sjøbring
Journal:  Mol Microbiol       Date:  1995-11       Impact factor: 3.501

6.  Influence of intranasal immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A streptococci.

Authors:  D Bessen; V A Fischetti
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

7.  Differences between Belgian and Brazilian group A Streptococcus epidemiologic landscape.

Authors:  Pierre Robert Smeesters; Anne Vergison; Dioclécio Campos; Eurico de Aguiar; Veronique Yvette Miendje Deyi; Laurence Van Melderen
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

8.  Functional dissection of Streptococcus pyogenes M5 protein: the hypervariable region is essential for virulence.

Authors:  Johan Waldemarsson; Margaretha Stålhammar-Carlemalm; Charlotta Sandin; Francis J Castellino; Gunnar Lindahl
Journal:  PLoS One       Date:  2009-10-01       Impact factor: 3.240

9.  Persistence of type-specific antibodies in man following infection with group A streptococci.

Authors:  R C LANCEFIELD
Journal:  J Exp Med       Date:  1959-08-01       Impact factor: 14.307

10.  TYPE-SPECIFIC PROTECTION AND IMMUNITY FOLLOWING INTRANASAL INOCULATION OF MONKEYS WITH GROUP A HEMOLYTIC STREPTOCOCCI.

Authors:  R F Watson; S Rothbard; H F Swift
Journal:  J Exp Med       Date:  1946-07-31       Impact factor: 14.307

View more
  119 in total

1.  Streptococcus pyogenes emm Types and Clusters during a 7-Year Period (2007 to 2013) in Pharyngeal and Nonpharyngeal Pediatric Isolates.

Authors:  F Koutouzi; A Tsakris; P Chatzichristou; E Koutouzis; G L Daikos; E Kirikou; N Petropoulou; V Syriopoulou; A Michos
Journal:  J Clin Microbiol       Date:  2015-04-15       Impact factor: 5.948

2.  Group A Streptococcus T Antigens Have a Highly Conserved Structure Concealed under a Heterogeneous Surface That Has Implications for Vaccine Design.

Authors:  Paul G Young; Jeremy M Raynes; Jacelyn M Loh; Thomas Proft; Edward N Baker; Nicole J Moreland
Journal:  Infect Immun       Date:  2019-05-21       Impact factor: 3.441

3.  An emm-type specific qPCR to track bacterial load during experimental human Streptococcus pyogenes pharyngitis.

Authors:  Loraine V Fabri; Kristy I Azzopardi; Joshua Osowicki; Hannah R Frost; Pierre R Smeesters; Andrew C Steer
Journal:  BMC Infect Dis       Date:  2021-05-21       Impact factor: 3.090

4.  Investigation of group A Streptococcus immune responses in an endemic setting, with a particular focus on J8.

Authors:  Patricia Therese Campbell; Hannah Frost; Pierre R Smeesters; Joseph Kado; Michael F Good; Michael Batzloff; Nicholas Geard; Jodie McVernon; Andrew Steer
Journal:  Vaccine       Date:  2018-11-03       Impact factor: 3.641

5.  Polymorphisms in Regulator of Cov Contribute to the Molecular Pathogenesis of Serotype M28 Group A Streptococcus.

Authors:  Paul E Bernard; Priyanka Kachroo; Jesus M Eraso; Luchang Zhu; Jessica E Madry; Sarah E Linson; Matthew Ojeda Saavedra; Concepcion Cantu; James M Musser; Randall J Olsen
Journal:  Am J Pathol       Date:  2019-07-29       Impact factor: 4.307

6.  Human IgG Increases Virulence of Streptococcus pyogenes through Complement Evasion.

Authors:  David Ermert; Antonin Weckel; Michal Magda; Matthias Mörgelin; Jutamas Shaughnessy; Peter A Rice; Lars Björck; Sanjay Ram; Anna M Blom
Journal:  J Immunol       Date:  2018-04-06       Impact factor: 5.422

Review 7.  Molecular epidemiology and genomics of group A Streptococcus.

Authors:  Debra E Bessen; W Michael McShan; Scott V Nguyen; Amol Shetty; Sonia Agrawal; Hervé Tettelin
Journal:  Infect Genet Evol       Date:  2014-10-30       Impact factor: 3.342

8.  M-protein based vaccine induces immunogenicity and protection from Streptococcus pyogenes when delivered on a high-density microarray patch (HD-MAP).

Authors:  Jamie-Lee S Mills; Cesar M Jayashi Flores; Manisha Pandey; Michael F Good; Simone Reynolds; Christine Wun; Ainslie Calcutt; S Ben Baker; Senthil Murugappan; Alexandra C I Depelsenaire; Jessica Dooley; Paul V Fahey; Angus H Forster
Journal:  NPJ Vaccines       Date:  2020-08-07       Impact factor: 7.344

Review 9.  Variation, Indispensability, and Masking in the M protein.

Authors:  Partho Ghosh
Journal:  Trends Microbiol       Date:  2017-08-31       Impact factor: 17.079

10.  Prevalence and molecular diversity of invasive Streptococcus dysgalactiae and Streptococcus pyogenes in a German tertiary care medical centre.

Authors:  S Rößler; R Berner; E Jacobs; N Toepfner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-05-03       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.